Ensign Peak Advisors Portfolio holdings
AUM
$58.4B
1-Year Return
23.83%
This Quarter Return
-3.67%
1 Year Return
+23.83%
3 Year Return
+106.64%
5 Year Return
+193.2%
10 Year Return
–
AUM
$40.3B
AUM Growth
-$1.82B
(-4.3%)
Cap. Flow
+$271M
Cap. Flow
% of AUM
0.67%
Top 10 Holdings %
Top 10 Hldgs %
25.24%
Holding
2,395
New
237
Increased
785
Reduced
642
Closed
83
Top Buys
| 1 |
Mastercard
MA
|
+$198M |
| 2 |
Gilead Sciences
GILD
|
+$110M |
| 3 |
PG&E
PCG
|
+$109M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$79.2M |
| 5 |
Allstate
ALL
|
+$64.6M |
Top Sells
| 1 |
Visa
V
|
+$472M |
| 2 |
AbbVie
ABBV
|
+$113M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$61.4M |
| 4 |
Home Depot
HD
|
+$58.3M |
| 5 |
Salesforce
CRM
|
+$54.6M |
Sector Composition
| 1 | Technology | 20.24% |
| 2 | Healthcare | 19.03% |
| 3 | Financials | 13.01% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 7.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1701
AngioDynamics
ANGO
$445M
| $306K | ﹤0.01% |
14,960
| – | – |
|
1702
Green Dot
GDOT
$757M
| $304K | ﹤0.01% |
16,009
| – | – |
|
1703
Provident Financial Services
PFS
$2.59B
| $304K | ﹤0.01% |
15,600
| – | – |
|
1704
Aurinia Pharmaceuticals
AUPH
$1.61B
| $302K | ﹤0.01% |
40,150
+7,440
| +23% | +$56K |
|
1705
Zumiez
ZUMZ
$356M
| $302K | ﹤0.01% |
14,040
| – | – |
|
1706
Celldex Therapeutics
CLDX
$1.66B
| $301K | ﹤0.01% |
10,710
| – | – |
|
1707
Madrigal Pharmaceuticals
MDGL
$9.59B
| $298K | ﹤0.01% |
4,580
-8,508
| -65% | -$554K |
|
1708
Vanda Pharmaceuticals
VNDA
$265M
| $298K | ﹤0.01% |
30,160
| – | – |
|
1709
JFrog
FROG
$5.8B
| $297K | ﹤0.01% |
13,430
| – | – |
|
1710
FibroGen
FGEN
$46.5M
| $296K | ﹤0.01% |
910
+142
| +18% | +$46.2K |
|
|
B
1711
DELISTED
Barnes Group Inc.
B
| $296K | ﹤0.01% |
10,262
| – | – |
|
1712
Samsara
IOT
$22.2B
| $295K | ﹤0.01% |
24,430
+6,920
| +40% | +$83.6K |
|
1713
MannKind Corp
MNKD
$1.71B
| $292K | ﹤0.01% |
94,630
+35,890
| +61% | +$111K |
|
1714
Pegasystems
PEGA
$9.66B
| $292K | ﹤0.01% |
18,200
+6,180
| +51% | +$99.2K |
|
1715
Calavo Growers
CVGW
$479M
| $291K | ﹤0.01% |
9,152
-2,080
| -19% | -$66.1K |
|
|
PYCR
1716
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $291K | ﹤0.01% |
+9,850
| New | +$291K |
|
|
NVRO
1717
DELISTED
NEVRO CORP.
NVRO
| $291K | ﹤0.01% |
6,240
| – | – |
|
|
NEX
1718
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $291K | ﹤0.01% |
39,380
+32,960
| +513% | +$244K |
|
1719
Revolution Medicines
RVMD
$7.56B
| $289K | ﹤0.01% |
14,640
+2,650
| +22% | +$52.3K |
|
|
MYOV
1720
DELISTED
Myovant Sciences Ltd.
MYOV
| $289K | ﹤0.01% |
16,100
+6,480
| +67% | +$116K |
|
|
DEA
1721
Easterly Government Properties
DEA
$1.06B
| $288K | ﹤0.01% |
7,316
| – | – |
|
1722
Haverty Furniture Companies
HVT
$380M
| $288K | ﹤0.01% |
11,550
| – | – |
|
1723
Jamf
JAMF
$1.3B
| $288K | ﹤0.01% |
13,000
| – | – |
|
1724
Materion
MTRN
$2.29B
| $288K | ﹤0.01% |
3,600
+1,910
| +113% | +$153K |
|
|
SLCA
1725
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $288K | ﹤0.01% |
26,330
-10,960
| -29% | -$120K |
|